Telemedicine in epilepsy management during the coronavirus disease 2019 pandemic.
comorbidity
epilepsy management
etiology
face-to-face visits
telemedicine
Journal
Pediatrics international : official journal of the Japan Pediatric Society
ISSN: 1442-200X
Titre abrégé: Pediatr Int
Pays: Australia
ID NLM: 100886002
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
revised:
22
07
2021
received:
22
05
2021
accepted:
26
08
2021
pubmed:
31
8
2021
medline:
3
5
2022
entrez:
30
8
2021
Statut:
ppublish
Résumé
Telemedicine has spread rapidly during the coronavirus disease 2019 (COVID-19) pandemic and shown its usefulness, particularly for patients with epilepsy, compared to face-to-face visits. We sought to evaluate the clinical features of patients with childhood onset epilepsy associated with consultations by telephone call during the COVID-19 pandemic. We retrospectively investigated the medical records of patients with childhood onset epilepsy who visited an outpatient clinic in Saitama Children's Medical Center, Saitama, Japan, from 1 March 2020 to 30 September 2020. To find the clinical features of patients who utilized telemedicine consultation (by telephone call), we divided the patients into the telemedicine group and the face-to-face group. We then reviewed the clinical features. Telemedicine consultation was not implemented for new patients. We enrolled 776 outpatients in total, and 294 patients (37.9%) utilized telemedicine consultations. The total number of visits was 2,299 and the total number of telemedicine consultations was 373 (16.2%). No clinical feature was associated with telemedicine consultations except for age at onset of epilepsy. The number of oral antiepileptic drugs prescriptions decreased in 23 of 776 (3.0%) of the patients who did not experience seizure deterioration, including status epilepticus, or who visited the emergency room. Telemedicine consultations were successfully utilized for epilepsy treatment at our outpatient clinic, regardless of epilepsy type, etiology, seizure frequency, comorbidities, and patients' residential areas. Thus, telemedicine by telephone call may be a useful resource in the management of patients with childhood onset epilepsy during the pandemic.
Sections du résumé
BACKGROUND
BACKGROUND
Telemedicine has spread rapidly during the coronavirus disease 2019 (COVID-19) pandemic and shown its usefulness, particularly for patients with epilepsy, compared to face-to-face visits. We sought to evaluate the clinical features of patients with childhood onset epilepsy associated with consultations by telephone call during the COVID-19 pandemic.
METHODS
METHODS
We retrospectively investigated the medical records of patients with childhood onset epilepsy who visited an outpatient clinic in Saitama Children's Medical Center, Saitama, Japan, from 1 March 2020 to 30 September 2020. To find the clinical features of patients who utilized telemedicine consultation (by telephone call), we divided the patients into the telemedicine group and the face-to-face group. We then reviewed the clinical features. Telemedicine consultation was not implemented for new patients.
RESULTS
RESULTS
We enrolled 776 outpatients in total, and 294 patients (37.9%) utilized telemedicine consultations. The total number of visits was 2,299 and the total number of telemedicine consultations was 373 (16.2%). No clinical feature was associated with telemedicine consultations except for age at onset of epilepsy. The number of oral antiepileptic drugs prescriptions decreased in 23 of 776 (3.0%) of the patients who did not experience seizure deterioration, including status epilepticus, or who visited the emergency room.
CONCLUSION
CONCLUSIONS
Telemedicine consultations were successfully utilized for epilepsy treatment at our outpatient clinic, regardless of epilepsy type, etiology, seizure frequency, comorbidities, and patients' residential areas. Thus, telemedicine by telephone call may be a useful resource in the management of patients with childhood onset epilepsy during the pandemic.
Identifiants
pubmed: 34460985
doi: 10.1111/ped.14972
pmc: PMC8661659
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14972Subventions
Organisme : Arthritis Research UK
ID : FC001039
Pays : United Kingdom
Organisme : MHLW Research program on rare and intractable diseases
ID : JPMH20FC1039
Informations de copyright
© 2021 Japan Pediatric Society.
Références
Chua R, Craig J, Wootton R, Patterson V. Randomised controlled trial of telemedicine for new neurological outpatient referrals. J. Neurol. Neurosurg. Psychiatry 2001; 71: 63-6.
Rasmusson K, Hartshorn JC. A comparison of epilepsy patients in a traditional ambulatory clinic and a telemedicine clinic. Epilepsia 2005; 46: 767-70.
Bahrani K, Singh MB, Bhatia R et al. Telephonic review for outpatients with epilepsy-A prospective randomized, parallel group study. Seizure 2017; 53: 55-61.
Lo MD, Gospe SM. Telemedicine and child neurology. J. Child. Neurol. 2019; 34: 22-6.
Hatcher-Martin JM, Adams JL, Anderson ER et al. Telemedicine in neurology. Neurology 2020; 94: 30-8.
Sattar S, Kuperman R. Telehealth in pediatric epilepsy care: a rapid transition during the COVID-19 pandemic. Epilepsy Behav. 2020; 111: 107282.
Fortini S, Espeche A, Caraballo R. Telemedicine and epilepsy: a patient satisfaction survey of a pediatric remote care program. Epilepsy Res. 2020; 165: 106370.
Kuchenbuch M, D'Onofrio G, Wirrell E et al. An accelerated shift in the use of remote systems in epilepsy due to the COVID-19 pandemic. Epilepsy Behav. 2020; 112: 107376.
Sanchez-Larsen A, Gonzalez-Villar E, Díaz-Maroto I et al. Influence of the COVID-19 outbreak in people with epilepsy: analysis of a Spanish population (EPICOVID registry). Epilepsy Behav. 2020; 112: 107396.
Rametta SC, Fridinger SE, Gonzalez AK et al. Analyzing 2,589 child neurology telehealth encounters necessitated by the COVID-19 pandemic. Neurology 2020; 95: e1257-66.
Alkhotani A, Siddiqui MI, Almuntashri F, Baothman R. The effect of COVID-19 pandemic on seizure control and self-reported stress on patient with epilepsy. Epilepsy Behav. 2020; 112: 107323.
Reilly C, Muggeridge A, Cross JH. The perceived impact of COVID-19 and associated restrictions on young people with epilepsy in the UK: young people and caregiver survey. Seizure 2021; 85: 111-4.
Mostacci B, Licchetta L, Cacciavillani C et al. The impact of the COVID-19 pandemic on people with epilepsy. An Italian survey and a global perspective. Front. Neurol. 2020; 11: 613719.
Assenza G, Lanzone J, Brigo F et al. Epilepsy care in the time of COVID-19 pandemic in Italy: risk factors for seizure worsening. Front. Neurol. 2020; 11: 737.
Rosengard JL, Donato J, Ferastraoaru V et al. Seizure control, stress, and access to care during the COVID-19 pandemic in New York City: the patient perspective. Epilepsia 2021; 62: 41-50.
Puteikis K, Jasionis A, Mameniškienė R. Recalling the COVID-19 lockdown: insights from patients with epilepsy. Epilepsy Behav. 2021; 115: 107573.
Pasca L, Zanaboni MP, Grumi S et al. Impact of COVID-19 pandemic in pediatric patients with epilepsy with neuropsychiatric comorbidities: a telemedicine evaluation. Epilepsy Behav. 2020; 115: 107519.
Huang S, Wu C, Jia Y et al. COVID-19 outbreak: the impact of stress on seizures in patients with epilepsy. Epilepsia 2020; 61: 1884-93.
Panda PK, Dawman L, Panda P, Sharawat IK. Feasibility and effectiveness of teleconsultation in children with epilepsy amidst the ongoing COVID-19 pandemic in a resource-limited country. Seizure 2020; 81: 29-35.
Miyasaka M. Is BCG vaccination causally related to reduced COVID-19 mortality? EMBO Mol. Med. 2020; 12: e12661.
Watanabe M. The COVID-19 pandemic in Japan. Surg. Today 2020; 50: 787-93.
Kodera S, Rashed EA, Hirata A. Correlation between COVID-19 morbidity and mortality rates in Japan and local population density, temperature, and absolute humidity. Int. J. Environ. Res. Public Health 2020; 17: 5477.
French JA, Brodie MJ, Caraballo R et al. Keeping people with epilepsy safe during the COVID-19 pandemic. Neurology 2020; 94: 1032-7.